Registration - Consultant

Sanofi Canada / Sanofi Canada / CARL BALTARE, Consultant

Registration Information

Client name: Sanofi Canada / Sanofi Canada
Previous client names
Lobbyist name: CARL BALTARE, Consultant
Initial registration start date: 2005-04-26
Registration status: Inactive
Registration Number: 776307-3842

Associated Communications

Total Number of Communication Reports: 5

Monthly communication reports in the last 6 months: 0

Version 8 of 12 (2008-08-07 to 2010-02-25)

Registration versions:

Version 8 of 12 (2008-08-07 to 2010-02-25)

Lobbying Information

Subject Matters

Aboriginal Affairs
Consumer Issues
Health
Industry
Intellectual Property
International Relations
International Trade
Science and Technology

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with repect to consumer products
Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with repect to therapeutic products

Policies or Program

Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Health Canada Blueprint for Renewal: Modernizing Regulatory System for Health Products and Food (formerly Bill C-51)
National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on a common formulary
National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on catastrophic drug coverage
National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on expensive drugs for rare diseases
National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on pricing and purchasing strategies
Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
Patient Wait Time Guarantees (PWTGs) with respect to priority areas for patient wait times reductions
Patient Wait Time Guarantees (PWTGs) with respect to agreements with the provinces
Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy

Policies or Program, Regulation

Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Patent Act as it relates to the regulation of intellectual property for therapeutic products

Regulation

Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
Food and Drugs Act Regulations, specficially with respect to approval, regulation and life-cycle management of therapeutic products
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically proposed amendments to the Patented Medicines (Notice of Compliance) Regulations.
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Canadian Intellectual Property Office
Health Canada (HC)
Industry Canada
Justice Canada (JC)
Patented Medicine Prices Review Board (PMPRB)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
2150 ST ELZEAR BLVD
LAVAL, QC H7L 4A8
Canada

Telephone number: 514-956-4098

Client representative

MICHEL TREMBLAY, Director, Federal Governemnt and National Stakeholder Relations

Parent Company Information

SANOFI AVENTIS
- 174 AVE. DE FRANCE
  PARIS 75013
  France

Coalition Members Information

SANOFI AVENTIS CANADA is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

AVENTIS PHARMA GERMANY GMBH
- BUILDING F821 INDUSTRIAL ESTATE
  HOESCHT 65926
  Germany
DERMIK LABORATORIES INC
- 1050 WESTLAKES DRIVE
  BERWYN, PA 19312
  United States of America
MERIAL LIMITED
- SANDRINGHAM HOUSE HARLOW BUSINESS PARK
  ESSEX CM195TG
  United Kingdom
SANOFI PASTEUR INC
- DISCOVERY DRIVE
  SWIFTWATER, PA 18370
  United States of America
SANOFI PASTEUR MSD LTD
- MALLARDS REACH BRIDGE AVENUE
  MAIDENHEAD SL61QP
  United Kingdom

Subsidiary Beneficiary Information

SANOFI AVENTIS CANADA does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

CARL BALTARE | Public offices held

Business address:
50 O'CONNOR ST.
SUITE 901
OTTAWA, ON K1P 6L2
Canada

Telephone number: 613-783-3438
Fax number: 613-782-2426

Consultant Firm and Address

Firm: GLOBAL PUBLIC AFFAIRS

Address:
50 O'CONNOR ST. SUITE 901
OTTAWA, ON K1P 6L2
Canada

Telephone number: 613-783-3438
Fax number: 613-782-2426

Sanofi Canada/Sanofi Canada

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Sanofi Canada/Sanofi Canada	2015-02-04	2016-07-15
SANOFI AVENTIS CANADA	2008-08-07	2015-02-04

The following names have been used before July 2, 2008

SANOFI AVENTIS CANADA
SANOFI-AVENTIS
SANOFI-AVENTIS

Sanofi Canada / Sanofi Canada

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

CARL BALTARE, GLOBAL PUBLIC AFFAIRS (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-5 of 5

Sanofi Canada
Consultant: CARL BALTARE

Designated Public Office Holders who participated in the communication:
- Neil Brodie, Director of Policy | Office of the Minister of Industry | Industry Canada
Subject Matter of the communication: Industry
Communication date: 2011-02-07
Posted date: 2011-03-16
Communication number: 3842-165726 View associated registration
Sanofi Canada
Consultant: CARL BALTARE

Designated Public Office Holders who participated in the communication:
- Tim Vail, Director of Communications | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2009-07-02
Posted date: 2009-08-17
Communication number: 3842-116338 View associated registration
Sanofi Canada
Consultant: CARL BALTARE

Designated Public Office Holders who participated in the communication:
- William King, Chief of Staff | Office of the Minister of Industry | Industry Canada
Subject Matter of the communication: Science and Technology
Communication date: 2009-04-09
Posted date: 2009-05-16
Communication number: 3842-105331 View associated registration
Sanofi Canada
Consultant: CARL BALTARE

Designated Public Office Holders who participated in the communication:
- Stephen Kelly, Senior Policy Advisor | Minister of Industry | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2008-07-10
Posted date: 2008-08-16
Communication number: 3842-77504 View associated registration
Sanofi Canada
Consultant: CARL BALTARE

Designated Public Office Holders who participated in the communication:
- Siddika Mithani, Associate Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2008-07-09
Posted date: 2008-08-16
Communication number: 3842-77492 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Intern Department of Public Works, Electronic Data Processing Procurement	May 1974 to August 1974	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Intern Department of Public Works, Electronic Data Processing Procurement	May 1974 to August 1974	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Sanofi Canada / Sanofi Canada / CARL BALTARE, Consultant

Registration Information

Associated Communications

Version 8 of 12 (2008-08-07 to 2010-02-25)

Version 8 of 12 (2008-08-07 to 2010-02-25)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address